<DOC>
	<DOCNO>NCT00223275</DOCNO>
	<brief_summary>The abuse alcohol especially common people bipolar disorder . However , little known treat people bipolar disorder alcohol abuse/dependence . The purpose research determine whether naltrexone add-on therapy associate great reduction alcohol use alcohol crave placebo ( inactive substance ) therapy .</brief_summary>
	<brief_title>Naltrexone Bipolar Disorder Alcohol Dependence</brief_title>
	<detailed_description>A 12-week , randomize , double-blind , parallel-group , placebo-controlled trial naltrexone conduct 50 English- Spanish-speaking outpatient bipolar I disorder II disorder current alcohol dependence . At baseline appointment , informed consent obtain , assessment procedure , include review inclusion exclusion criterion , perform . The SCID ( Structured Clinical Interview DMS-IV Axis I Disorders perform establish diagnosis bipolar I II disorder alcohol dependence . A psychiatrist confirm SCID diagnosis obtain RA . Eligible participant give Hamilton Rating Scale Depression 17-item version ( HRSD17 ) , Inventory Depressive Symptomatology-Self-Report 30-item version ( IDS-SR30 ) , Young Mania Rating Scale ( YMRS ) , Penn Alcohol Craving Scale ( PACS ) , Addiction Severity Index ( ASI ) , Psychobiology Recovery Depression III Somatic Symptom Scale ( PRD-III ) , urine drug screen . Recent alcohol use ( present substance use ) assess use Timeline Followback ( TLFB ) method , drink define 13.6g absolute alcohol ( approximately 12 oz ( 341 mL ) beer , 5 oz wine , 3 oz fortify wine , 1.5 oz 80 proof liquor ) . Length problem alcohol use assess asking , `` When alcohol first start cause problem ? '' Blood drawn routine laboratory analysis include complete blood count ( CBC ) SMA-20 ( include liver panel GGT , AST , ALT , Billirubin ) baseline ( week 0 ) completion ( week 12 ) . Blood also draw week 4 8 repeat test GGT level . A physical examination perform baseline . Women childbearing potential receive urine pregnancy test counsel effective contraceptive method . A psychiatrist ass participant baseline weekly follow-up visit , participate inform consent process . Study medication give second appointment result liver function test receive ( generally 1-2 day first appointment ) . At weekly assessment HRSD17 , IDS-R30 , YMRS , assessment alcohol use past week , urine drug screen obtain . Urine drug screen obtain newly enrol subject . We obtain urine drug screen subject already active study . In addition , participant receive total 16 one-hour/week session manual-driven CBT specifically design person bipolar disorder substance abuse , provide bilingual psychologist experience CBT . Patients discontinue study medication week 12 , continue CBT therapy week 16 . Pill count conducted weekly assessment visit . In addition , weekly assessment , participant ask adherence psychotropic medication use modified version assessment develop Weiss et al. , estimate percent prescribe medication actually take record .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>INCLUSION CRITERIA : English Spanishspeaking Age 1870 Diagnosis bipolar I II . Current mood state depress mixed . Alcohol use least 5 drink past 7 day . Current diagnosis alcohol dependence . EXCLUSION CRITERIA : Bipolar disorder bipolar I II disorder ( e.g. , bipolar NOS , cyclothymic disorder , schizophrenia , schizoaffective disorder , unipolar ) . Lifetime opiate abuse dependence current use ( include prescription drug ) . Diagnosis current dependence substance alcohol ( participant abuse substance include . Dependence caffeine and/or nicotine allow . ) Severe lifethreatening medical illness ( e.g. , hepatic cirrhosis , congestive heart failure , terminal cancer ) lab consistent serious medical illness ( e.g. , severe edema , atrial fibrillation , dangerously abnormal electrolyte ) . Pregnant nursing female High risk suicide define ≥2 suicide attempt past 12 month require medical attention , current suicidal ideation plan intent . Prior therapy naltrexone and/or allergic reaction naltrexone . Current therapy acamprosate disulfiram . Member vulnerable population ( Dementia , cognitively impaired , mental retardation , prisoner ) Baseline YMRS HRSD17 score ≥ 30 . AST , ALT , bilirubin &gt; 3 time upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Alcohol Dependence</keyword>
	<keyword>Dual Diagnosis</keyword>
	<keyword>Naltrexone</keyword>
</DOC>